SFI Health Expands Equazen® Reach with Curasense Licensing Deal

SFI HealthTM EMEA has entered into an exclusive licensing agreement with Curasense BV for the distribution of Equazen® food supplements in the Netherlands and Belgium. This partnership, announced on September 25, 2025, enables Curasense to promote, market, and sell Equazen® products featuring a clinically researched blend of essential fatty acids.

Curasense, a Belgian company focused on high-quality nutraceuticals, will take charge of Equazen®’s commercial activities following a transition from SFI HealthTM’s previous licensee. The agreement positions Equazen® to leverage a robust network of over 6,500 pharmacies and health stores across both countries, which includes approximately 800 independent stores in Belgium and 2,000 outlets in the Netherlands. With increasing online demand, this collaboration is expected to enhance the brand’s visibility and distribution in these key markets.

Matthew Brabazon, General Manager of SFI HealthTM EMEA, expressed enthusiasm for the partnership, stating, “We are very pleased to collaborate with Curasense, a company with extensive experience in the healthcare sector and a strong reputation among healthcare professionals and consumers.” He emphasized the strategic importance of this collaboration in reinforcing the Equazen® brand and expanding its market presence, particularly in brain health and cognitive wellness.

In response, Jelle D’Helft, CEO of Curasense, highlighted the alignment of the partnership with their mission. “This agreement is a natural extension of our commitment to delivering evidence-based health solutions,” he remarked. “Equazen®’s clinically supported formulations reflect our ambition to bridge conventional and complementary medicine, accelerating access to science-backed products for consumers of all ages.”

The brain health supplement market is among the fastest growing segments in the global food supplements sector. In Europe, it is anticipated to grow at a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030. This growth is driven by a rising consumer focus on maintaining cognitive function and mental health, positioning Equazen® to capitalize on the increasing demand.

Equazen® is already established in various EMEA markets, including Spain, Portugal, the United Kingdom, Switzerland, Poland, the Czech Republic, Slovakia, and the Nordics. SFI HealthTM aims to broaden its reach and unlock the full sales potential of the brand as it continues to navigate the evolving landscape of the nutraceutical industry.

SFI HealthTM is recognized as a global leader in natural healthcare, specializing in the development of clinically researched products targeting microbiome health, cognition, and overall wellbeing. The company’s headquarters is located in Australia, with the EMEA region managed from Lugano, Switzerland. SFI HealthTM prides itself on a rigorous approach to natural solutions and maintains an extensive network of partners to ensure its products reach consumers in over 50 countries.

Curasense BV, based in Heist-op-den-Berg, Antwerp, has two decades of experience in the healthcare sector, focusing on innovative nutraceuticals that address cognitive function, inflammation management, and overall vitality. The company’s commitment to scientific substantiation and compliance with European regulations ensures that its products are of proven quality and effectiveness, further supporting its mission to provide advanced health solutions across Europe.

Equazen® itself is recognized as a scientifically validated food supplement designed to support cognitive health throughout all life stages. Each product in the Equazen® range contains a carefully balanced mix of essential fatty acids, which have been clinically proven over more than 20 years to enhance learning capabilities and healthy brain development. Now marketed in 30 countries, Equazen® has gained the trust of healthcare professionals and families alike, cementing its role as a leader in the nutraceutical market.

For more information about SFI HealthTM and its product lines, visit sfihealth.com. To learn more about Curasense, please visit curasense.com.